Deoxypodophyllotoxin induces apoptosis in non-small cell lung cancer cells by targeting the glucocorticoid receptor
Authors:
- 23 July 2025
- journal article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 772, 110561
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Dynamic RBM47 ISGylation confers broad immunoprotection against lung injury and tumorigenesis via TSC22D3 downregulationCell Death Discovery, 2023
- TSC22D3 as an immune-related prognostic biomarker for acute myeloid leukemiaiScience, 2023
- A comprehensive insight into the antineoplastic activities and molecular mechanisms of deoxypodophyllotoxin: Recent trends, challenges, and future outlookEuropean Journal of Pharmacology, 2022
- Dexamethasone enhances the lung metastasis of breast cancer via a PI3K-SGK1-CTGF pathwayOncogene, 2021
- Glucocorticoid receptor modulatorsAnnales d'Endocrinologie, 2018
- Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancerNature Communications, 2015
- Deoxypodophyllotoxin: A promising therapeutic agent from herbal medicineJournal of Ethnopharmacology, 2013
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and SurvivorshipMayo Clinic Proceedings, 2008
- Nuclear Receptor Coregulators: Judges, Juries, and Executioners of Cellular RegulationMolecular Cell, 2007
- Immunocytochemical analysis of the glucocorticoid receptor alpha isoform (GRα) using a GRα-specific antibodySteroids, 1999